Previous workers reviewed the change of human hepatic CYP450 enzymes in NAFLD, such as CYP2E1,3A4, 1A2, 2A6, 2B6, 2C8, 2C9, and 2C19 (199). Here, CYP2E1 is linked to metabolic dysfunction-associated steatotic liver disease.